• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
DGX

DGX

Quest Diagnostics Incorporated

NYSEHealthcareMedical - Diagnostics & ResearchUS

USD193.67

+0.51 (+0.26%)

Rating:B+

Company Profile

CEO

James E. Davis

IPO Date

1996-12-17

Sector

Healthcare

Industry

Medical - Diagnostics & Research

Exchange

NYSE

Country

US

Market Metrics

Open

$193.00

Prev. Close

$193.16

Day Low

$192.38

Day High

$195.22

52W Low

$164.65

52W High

$213.50

Market Cap

$21.44B

Volume

0.42M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

43.1%

Avg Negative

32.6%

Avg Neutral

24.4%

News Feed

Are Medical Stocks Lagging Quest Diagnostics (DGX) This Year?

zacks.com·5/26/2026·↑ positive

Why Is Quest Diagnostics (DGX) Down 5% Since Last Earnings Report?

zacks.com·5/21/2026·↓ negative

Is This the Right Time to Hold DGX Stock in Your Portfolio?

zacks.com·
5/19/2026
·↑ positive

Quest Diagnostics: Updating Levels After Q1 Earnings

seekingalpha.com·5/7/2026·↑ positive

Quest Diagnostics Prices $500 Million of Senior Notes

prnewswire.com·4/27/2026·↑ positive

AEGON ASSET MANAGEMENT UK Plc Decreases Stake in Quest Diagnostics Incorporated $DGX

defenseworld.net·4/26/2026·↓ negative

Quest Diagnostics: Good Q1, Solid Business, Steady Share Price Upside Likely

seekingalpha.com·4/24/2026·↓ negative

Quest Diagnostics Incorporated $DGX Stock Holdings Decreased by Cwm LLC

defenseworld.net·4/24/2026·↓ negative

These Analysts Boost Their Forecasts On Quest Diagnostics After Better-Than-Expected Earnings

benzinga.com·4/22/2026·↑ positive

Is Quest Diagnostics Inc (DGX) Overvalued After 4.5% Rally? GF Value Says Overvalued

gurufocus.com·4/21/2026·↑ positive